Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
No Data Available.
Synonyms :
mebhydrolin
Class :
Antihistamine
Dosage forms and strengths Â
TabletÂ
50 mg
The suggested dose is 100 to 300 mg in a day by oral route
Dosage forms and strengthsÂ
TabletÂ
50 mgÂ
Age less than two years: The suggested dose is 50 to 100 mg in a day by oral route
Age 2 to 5 years: The suggested dose is 50 to 150 mg in a day by oral route
Age 5 to 10 years: The suggested dose is 100 to 200 mg in a day by oral route
Age more than ten years:
The suggested dose is 100 to 300 mg in a day by oral route
Age less than two years: The suggested dose is 50 to 100 mg in a day by oral route
Age 2 to 5 years: The suggested dose is 50 to 150 mg in a day by oral route
Age 5 to 10 years: The suggested dose is 100 to 200 mg in a day by oral route
Age more than ten years:
The suggested dose is 100 to 300 mg in a day by oral route
Refer adult dosingÂ
When droxidopa is used together with mebhydrolin, droxidopa's therapeutic effectiveness can be enhanced
When ephedrine is used together with mebhydrolin, ephedrine’s therapeutic effectiveness can be enhanced
When epinephrine is used together with mebhydrolin, epinephrine’s therapeutic effectiveness can be enhanced
When norepinephrine is used together with mebhydrolin, norepinephrine’s therapeutic effectiveness can be enhanced
When protokylol is used together with mebhydrolin, protokylol’s therapeutic effectiveness can be enhanced
When racepinephrine is used together with mebhydrolin, racepinephrine’s therapeutic effectiveness can be enhanced
Actions and Spectrum:Â
Action:Â
Antihistamine: mebhydrolin is primarily classified as a first-generation antihistamine. It works by binding to and blocking histamine receptors in the body, thereby reducing the symptoms associated with histamine release. This action helps alleviate allergic reactions.Â
Sedative: mebhydrolin also possesses sedative properties, which can induce drowsiness or sleepiness. This sedative effect can be beneficial for individuals experiencing allergy-related sleep disturbances.Â
Spectrum:Â
Allergic Rhinitis: mebhydrolin can relieve symptoms such as sneezing, runny nose, itching, and nasal congestion caused by allergic rhinitis (hay fever).Â
Frequency not defined Â
sleep disturbancesÂ
tremorÂ
myalgiaÂ
blood disordersÂ
epigastric painÂ
diarrhoeaÂ
vomitingÂ
nauseaÂ
sweatingÂ
Black Box Warning:Â Â
None
Contraindication/Caution:Â Â
Hypersensitivity: Do not use mebhydrolin if you are known to be hypersensitive or allergic to mebhydrolin or any of its components. Allergic reactions can be severe and life-threatening.Â
Narrow-Angle Glaucoma: mebhydrolin may increase intraocular pressure, which can be dangerous for individuals with narrow-angle glaucoma. It’s important to avoid using it if you have this condition.Â
Respiratory Depression: Avoid mebhydrolin in cases of severe respiratory depression, as it can further depress the respiratory system.Â
Pregnancy and Breastfeeding: A healthcare professional should carefully consider and supervise mebhydrolin during pregnancy and breastfeeding. It may have potential risks to the developing fetus or infant.Â
Children Under two Years: mebhydrolin is generally not recommended for use in children under two years old due to limited safety data in this age group.Â
Pregnancy warnings:    Â
Pregnancy category: N/AÂ
Lactation: Excreted into human milk is unknownÂ
Pregnancy Categories:        Â
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.Â
<b>Category B: There were a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments.  Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.  Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this category
Pharmacology: Â
mebhydrolin is an antihistamine and anticholinergic medication that relieves allergy symptoms.Â
Pharmacodynamics:Â Â
Antihistamine:
mebhydrolin acts as an antagonist at H1 histamine receptors, blocking the effects of histamine. By blocking H1 receptors, mebhydrolin reduces the symptoms associated with allergies.  Â
Pharmacokinetics:Â
AbsorptionÂ
mebhydrolin is usually administered orally in tablet or syrup form and is well-absorbed from the gastrointestinal tract.Â
DistributionÂ
The drug, including the central nervous system (CNS), is distributed throughout the body.Â
MetabolismÂ
mebhydrolin is metabolized in the liver, primarily through cytochrome P450 enzymes.Â
Excretion and EliminationÂ
The metabolites and the unchanged drug are excreted in urineÂ
Administration: Â
The route of administration is oral.Â
Patient information leafletÂ
Generic Name: mebhydrolinÂ
Why do we use mebhydrolin? Â
Relief from Allergic Symptoms: mebhydrolin is commonly prescribed to alleviate the symptoms associated with various allergies, including hay fever (allergic rhinitis), allergic conjunctivitis, and skin allergies. It helps reduce symptoms like sneezing, runny nose, itching, and watery eyes.Â